持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/08/22 | 1,232 | 1,235 | 1,222 | 1,231 | +11 | +0.9% | 32,000 |
| 2013/08/21 | 1,215 | 1,238 | 1,190 | 1,220 | +5 | +0.4% | 158,000 |
| 2013/08/20 | 1,210 | 1,251 | 1,210 | 1,215 | -19 | -1.5% | 94,000 |
| 2013/08/19 | 1,239 | 1,240 | 1,226 | 1,234 | +6 | +0.5% | 43,000 |
| 2013/08/16 | 1,229 | 1,234 | 1,220 | 1,228 | -3 | -0.2% | 51,000 |
| 2013/08/15 | 1,267 | 1,268 | 1,229 | 1,231 | -36 | -2.8% | 119,000 |
| 2013/08/14 | 1,251 | 1,280 | 1,246 | 1,267 | +16 | +1.3% | 82,000 |
| 2013/08/13 | 1,250 | 1,258 | 1,239 | 1,251 | +2 | +0.2% | 111,000 |
| 2013/08/12 | 1,255 | 1,270 | 1,247 | 1,249 | -5 | -0.4% | 28,000 |
| 2013/08/09 | 1,256 | 1,276 | 1,230 | 1,254 | +4 | +0.3% | 162,000 |
| 2013/08/08 | 1,247 | 1,278 | 1,245 | 1,250 | +8 | +0.6% | 93,000 |
| 2013/08/07 | 1,285 | 1,287 | 1,240 | 1,242 | -39 | -3% | 79,000 |
| 2013/08/06 | 1,300 | 1,300 | 1,248 | 1,281 | -19 | -1.5% | 131,000 |
| 2013/08/05 | 1,301 | 1,311 | 1,273 | 1,300 | ±0 | ±0% | 84,000 |
| 2013/08/02 | 1,287 | 1,300 | 1,273 | 1,300 | +13 | +1% | 105,000 |
| 2013/08/01 | 1,223 | 1,289 | 1,223 | 1,287 | +57 | +4.6% | 157,000 |
| 2013/07/31 | 1,238 | 1,270 | 1,216 | 1,230 | +1 | +0.1% | 139,000 |
| 2013/07/30 | 1,238 | 1,268 | 1,203 | 1,229 | -16 | -1.3% | 302,000 |
| 2013/07/29 | 1,320 | 1,346 | 1,225 | 1,245 | -49 | -3.8% | 256,000 |
| 2013/07/26 | 1,332 | 1,332 | 1,265 | 1,294 | -43 | -3.2% | 175,000 |
| 2013/07/25 | 1,388 | 1,388 | 1,318 | 1,337 | -60 | -4.3% | 133,000 |
| 2013/07/24 | 1,387 | 1,400 | 1,368 | 1,397 | +14 | +1% | 96,000 |
| 2013/07/23 | 1,375 | 1,384 | 1,359 | 1,383 | +10 | +0.7% | 115,000 |
| 2013/07/22 | 1,370 | 1,375 | 1,364 | 1,373 | +3 | +0.2% | 59,000 |
| 2013/07/19 | 1,393 | 1,393 | 1,368 | 1,370 | -25 | -1.8% | 109,000 |
| 2013/07/18 | 1,397 | 1,400 | 1,376 | 1,395 | +8 | +0.6% | 99,000 |
| 2013/07/17 | 1,386 | 1,392 | 1,363 | 1,387 | -14 | -1% | 109,000 |
| 2013/07/16 | 1,387 | 1,410 | 1,372 | 1,401 | +14 | +1% | 158,000 |
| 2013/07/12 | 1,377 | 1,403 | 1,368 | 1,387 | +12 | +0.9% | 132,000 |
| 2013/07/11 | 1,385 | 1,385 | 1,360 | 1,375 | -10 | -0.7% | 99,000 |
| 2013/07/10 | 1,400 | 1,401 | 1,371 | 1,385 | -12 | -0.9% | 151,000 |
| 2013/07/09 | 1,378 | 1,402 | 1,370 | 1,397 | +34 | +2.5% | 204,000 |
| 2013/07/08 | 1,385 | 1,393 | 1,362 | 1,363 | -8 | -0.6% | 127,000 |
| 2013/07/05 | 1,364 | 1,376 | 1,348 | 1,371 | +23 | +1.7% | 111,000 |
| 2013/07/04 | 1,345 | 1,358 | 1,341 | 1,348 | +6 | +0.4% | 78,000 |
| 2013/07/03 | 1,329 | 1,363 | 1,303 | 1,342 | +13 | +1% | 132,000 |
| 2013/07/02 | 1,299 | 1,350 | 1,283 | 1,329 | +51 | +4% | 172,000 |
| 2013/07/01 | 1,279 | 1,293 | 1,257 | 1,278 | +17 | +1.3% | 101,000 |
| 2013/06/28 | 1,211 | 1,274 | 1,211 | 1,261 | +56 | +4.6% | 204,000 |
| 2013/06/27 | 1,173 | 1,205 | 1,160 | 1,205 | +32 | +2.7% | 118,000 |
| 2013/06/26 | 1,220 | 1,224 | 1,173 | 1,173 | -32 | -2.7% | 94,000 |
| 2013/06/25 | 1,193 | 1,208 | 1,193 | 1,205 | +5 | +0.4% | 127,000 |
| 2013/06/24 | 1,235 | 1,235 | 1,195 | 1,200 | -37 | -3% | 155,000 |
| 2013/06/21 | 1,175 | 1,242 | 1,174 | 1,237 | +45 | +3.8% | 208,000 |
| 2013/06/20 | 1,225 | 1,225 | 1,191 | 1,192 | -46 | -3.7% | 200,000 |
| 2013/06/19 | 1,223 | 1,242 | 1,200 | 1,238 | +19 | +1.6% | 127,000 |
| 2013/06/18 | 1,248 | 1,252 | 1,205 | 1,219 | -4 | -0.3% | 167,000 |
| 2013/06/17 | 1,184 | 1,234 | 1,181 | 1,223 | +29 | +2.4% | 224,000 |
| 2013/06/14 | 1,169 | 1,230 | 1,169 | 1,194 | -5 | -0.4% | 318,000 |
| 2013/06/13 | 1,191 | 1,262 | 1,191 | 1,199 | -45 | -3.6% | 111,000 |
2751～
2800
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
